1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with hydrocortisone acetate in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (hydrocortisone acetate) | Trials (hydrocortisone acetate) | Recent Studies (post-2010) (hydrocortisone acetate) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 538 | 42 | 39 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hatakeyama, K; Watanabe, K; Yano, S | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and hydrocortisone acetate
Article | Year |
---|---|
Gastric bleeding and increased gastric vascular permeability induced by platelet activating factor (PAF): effect of drugs that affect arachidonate metabolism.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Caffeic Acids; Capillary Permeability; Dinoprostone; Gastric Mucosa; Gastrointestinal Hemorrhage; Hydrocortisone; Imidazoles; Indomethacin; Male; Perfusion; Phospholipid Ethers; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1991 |